SVS logo

Svas Biosana S.p.A. Stock Price

BIT:SVS Community·€45.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SVS Share Price Performance

€8.60
0.95 (12.42%)
€8.60
0.95 (12.42%)
Price €8.60

SVS Community Narratives

There are no narratives available yet.

Snowflake Analysis

Undervalued with proven track record.

4 Risks
4 Rewards

Svas Biosana S.p.A. Key Details

€135.0m

Revenue

€97.9m

Cost of Revenue

€37.1m

Gross Profit

€30.3m

Other Expenses

€6.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
1.27
27.48%
5.00%
112.9%
View Full Analysis

About SVS

Founded
1972
Employees
350
CEO
Umberto Perillo
WebsiteView website
svas.it

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications. In addition, the company provides specialist medical devices for use in oncology, intensive care, chronic illnesses, and surgeries; and medical devices for use in radiology and diagnostic imaging, orthopaedics, cardiology, heart surgery, and critical care applications. SVAS Biosana S.p.A. was founded in 1972 and is based in Somma Vesuviana, Italy.

Recent SVS News & Updates

Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

May 16
Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

Recent updates

No updates